SWMEDICAL.ORG
Supporting the Future of Mental Health Care
Madhukar Trivedi, M.D., Director of the CDRC, has led several studies to further our understanding of mental and mood disorders, leading or co-authoring hundreds of peer-reviewed journal articles covering a wide breadth of topics relating to brain health, spearheading a new wave of depression and mood disorder research.
Dr. Trivedi has co-authored more than 60 original research articles in the past year alone, including: T-MAP, STAR*D, CO-MED, REVAMP, EMBARC, DOSE, TREAD, STRIDE, PACES, CAST, ASCEND, ADAPT, D2K, and T-RAD.
REACHING MORE PEOPLE IN OUR COMMUNITY STRUGGLING TODAY
Through innovative programming, the CDRC has empowered thousands of students and families across our region to benefit from earlier diagnoses of depression and connection to the right resources for leading-edge, research-based treatment.
Twenty-seven primary care offices across North Texas have now embraced VitalSign6, an app-based software that has screened more than 76,000 patients for depression and helps physicians connect diagnosed patients to support and treatment options.
The Youth Aware of Mental Health (YAM) curriculum has connected thousands of local adolescents to mental health resources, equipping them with the tools and mechanisms to cope with potentially self-destructive behaviors and develop emotional awareness and intelligence. So far, YAM training has been provided for more than 14,000 North Texas middle school and high school students.
$10 MILLION LONE STAR PRIZE
Lyda Hill Philanthropies recently gave a transformative $10 million gift through the Lone Star Prize to Meadows Mental Health Policy Institute for their proposal to change the way we diagnose and treat mental illness. The proposal, called the “Lone Star Depression Challenge,” was created in partnership with the Center for Depression Research and Clinical Care at UT Southwestern Peter O'Donnell Jr. Brain Institute and Harvard Medical School’s Department of Global Health and Social Medicine. The prize represents a life-changing investment in the health of our community.
UNDERSTANDING TREATMENT
The CDRC continues driving transformative discoveries that are revolutionizing how we diagnose and treat mental and mood disorders. A recent breakthrough made possible by research conducted by the CDRC will bring more effective depression treatment to patients using artificial intelligence (AI) and brain scans.
This breakthrough will have a revolutionary impact on the field of psychiatry and the quality of patient care for patients with mental health disorders.
Additionally, the CDRC is in the process of developing a simple blood test with the power to inform depression diagnosis and treatment options based on each individual’s biological makeup.
BEHAVIORAL ACTIVATION THERAPY
AND PEDIATRIC PATIENTS
IMPLEMENTING THE PROGRAM
UNDERSTANDING ROOT CAUSES
VitalSign6, a web-based iPad application, is one piece of a comprehensive program meant to improve the process for identifying, screening, and treating depression. VitalSign6 began with the idea that mental health is a foundational aspect of overall wellness. Just like blood pressure and heart rate, the CDRC team has championed the notion that mental health should also be routinely measured and monitored, making it the sixth vital sign for which physicians screen.
Today, the profound impact of VitalSign6 has been felt in clinics in our community and beyond.
Recent media coverage of VitalSign6 has appeared in Annals of Family Medicine, on NPR, and in D CEO, bolstering education and messaging to the public.
UNDERSTANDING AWARENESS
In addition to increasing understanding so that health care professionals may better diagnose, treat, and prevent mental health disorders, the CDRC is promoting a greater understanding of what mental health is.
Through YAM, (Youth Aware of Mental Health) the CDRC has connected thousands of adolescents to mental health resources, equipping our next generation with the tools and mechanisms to cope with potentially self-destructive behaviors and develop emotional awareness and intelligence.
CDRC’s faculty and leadership has also gained more visibility, with Dr. Trivedi serving as the 2019 President of the American Society of Clinical Psychopharmacology (ASCP). Dr. Trivedi was also announced as the recipient of the American College of Psychiatrists 2019 Mood Disorders Reward.
A new satellite research clinic in Fort Worth celebrated its grand opening at the Moncrief Cancer Research Institute in January, 2020 showing promise for elevated efforts across our region and ultimately across our nation.
